153 related articles for article (PubMed ID: 22481646)
1. HLA and skin cancer.
Bonamigo RR; Carvalho AV; Sebastiani VR; Silva CM; Pinto AC
An Bras Dermatol; 2012; 87(1):9-16; quiz 17-8. PubMed ID: 22481646
[TBL] [Abstract][Full Text] [Related]
2. HLA and multiple skin carcinomas.
Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
[TBL] [Abstract][Full Text] [Related]
3. Lymphokine-activated killer (LAK) activity against autologous malignant tumors of the skin.
Fukui Y; Iseki R; Ohashi M
J Invest Dermatol; 1988 Oct; 91(4):319-22. PubMed ID: 3262690
[TBL] [Abstract][Full Text] [Related]
4. Skin cancers and HLA frequencies in renal transplant recipients.
Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
[TBL] [Abstract][Full Text] [Related]
5. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
[TBL] [Abstract][Full Text] [Related]
6. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.
Rass K; Reichrath J
Adv Exp Med Biol; 2008; 624():162-78. PubMed ID: 18348455
[TBL] [Abstract][Full Text] [Related]
7. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
[TBL] [Abstract][Full Text] [Related]
8. Regression of melanoma, but not keratoacanthoma, is associated with increased HLA-B22 and decreased HLA-B27 and HLA-DR1.
Lowes MA; Dunckley H; Watson N; Crotty K; Cooke B; Barnetson RS; Halliday GM
Melanoma Res; 1999 Dec; 9(6):539-44. PubMed ID: 10661764
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
10. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
[TBL] [Abstract][Full Text] [Related]
11. Multiple non-melanoma skin cancer: evidence that different MHC genes are associated with different cancers.
Czarnecki D; Tait B; Nicholson I; Lewis A
Dermatology; 1994; 188(2):88-90. PubMed ID: 8136554
[TBL] [Abstract][Full Text] [Related]
12. Melanoma and nonmelanoma skin cancers and the immune system.
Domingo DS; Baron ED
Adv Exp Med Biol; 2008; 624():187-202. PubMed ID: 18348457
[No Abstract] [Full Text] [Related]
13. Ultraviolet radiation and skin carcinogenesis.
Quinn AG
Br J Hosp Med; 1997 Sep 17-30; 58(6):261-4. PubMed ID: 9488800
[TBL] [Abstract][Full Text] [Related]
14. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of FAS and FAS ligand genes and risk of skin cancer.
Qureshi A; Nan H; Dyer M; Han J
J Dermatol Sci; 2010 Apr; 58(1):78-80. PubMed ID: 20219325
[No Abstract] [Full Text] [Related]
16. Lack of association between HLA-E polymorphism and primary cutaneous melanoma in Spanish patients.
Moya-Quiles MR; Martínez-Escribano J; Guerra-Perez N; Muro M; Marín L; Campillo JA; Montes-Ares O; Frias J; Minguela A; García-Alonso AM; Lozano JA; Alvarez-López MR
J Dermatol Sci; 2005 Oct; 40(1):62-4. PubMed ID: 16153808
[No Abstract] [Full Text] [Related]
17. Melanoma susceptibility variants on chromosome 20q11.22 are associated with pigmentary traits and the risk of nonmelanoma skin cancer.
Nan H; Qureshi AA; Han J
Br J Dermatol; 2010 Feb; 162(2):461-3. PubMed ID: 19995372
[No Abstract] [Full Text] [Related]
18. Association between MDM2 SNP309 and skin cancer: A meta-analysis of case-control studies.
Qin J; Cong X; Jin J; Chu Z; Gu X; Cai Y
J Dermatol Sci; 2015 Aug; 79(2):171-3. PubMed ID: 25979450
[No Abstract] [Full Text] [Related]
19. Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.
Yesantharao P; Wang W; Ioannidis NM; Demehri S; Whittemore AS; Asgari MM
Hum Immunol; 2017 Apr; 78(4):327-335. PubMed ID: 28185865
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to basal epidermal cells in patients with basal or squamous cell carcinoma.
Ackermann-Schopf CM
Arch Dermatol Res (1975); 1976 Dec; 257(2):149-56. PubMed ID: 1008612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
